A widely used non-prescription drug used in China to prevent and treat cataracts has been given the support of the scientific community.
Cataracts cause a clouding of the lens of the eye which is a leading cause of vision loss worldwide.
Drops containing pirenoxine or PRX have been reputed as a cataract remedy for almost 60 years in China.
In Western medicine, the only current treatment for cataracts is surgical replacement of the lens.
Now scientists have tested PRX on two different cloudy solutions that mimic the chemical composition of the eye lens in cataract patients.
The PRX reduced the cloudiness of one of the lens solutions by 38pc and of the other by 11pc.
“These results may provide a rationale for using PRX as an anti-cataract agent and warrant further biological studies” says the article published in Inorganic Chemistry.